NEU 3.50% $14.05 neuren pharmaceuticals limited

Neuren - where to from here ?, page-90

  1. 407 Posts.
    lightbulb Created with Sketch. 1256
    Maybe. Although I don't think it's ever that black & white. They're clearly correlated, but by how much who knows. I don't think one phase II success guarantees the other three will be successful and an independent 3rd party valuing Neuren (i.e. an acquirer) likely won't either.

    Regarding failure - well currently at quarter-time we're ahead one-nil on that.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.